Global biomedical market analysis
Market size analysis
In recent years, the global biopharmaceutical market has been accelerating. According to PMR research data, the global biopharmaceutical market value in 2009 was 101.66 billion US dollars, the market value in 2013 reached 146.55 billion US dollars, the CAGR of 2009-2013 was 9.6%; the market value in 2014 was 161.05 billion US dollars. In 2016, the market value was US$199.14 billion, and the CAGR for 2014-2016 was 11.2%.
Chart 1: 2009-2016 global biomedical market scale chart (unit: billion US dollars, %)
Source: PMR Prospective Industry Research Institute
Competitive landscape analysis
Biopharmaceuticals are a happy technology industry with high requirements for advanced production factors such as talent, capital and technology. The competitiveness of a country's biomedical industry is closely related to the degree of aggregation of high-level factors. At present, the global biomedical industry is in a state of agglomeration development, mainly concentrated in the United States, Europe, Japan, South Korea, Singapore, China and other countries and regions. Among them, the US biomedical industry has established intergenerational advantages in the world, and its research and development strength and industrial development are leading the world. Biopharmaceuticals have been widely used in the treatment of cancer, diabetes and chronic diseases. In 2016, the global bio-pharmaceutical market alone accounted for 40.93% of the total. Among the 50 most innovative companies in the world, the MIT Technology Review ranked 15 biopharmaceutical companies, 12 of which are located in the United States.
Figure 2: Analysis of the global biomedical industry competition pattern in 2016 (unit: %)
Source: PMR Prospective Industry Research Institute
Analysis of China's biomedical market
In recent years, the Chinese government has vigorously supported the development of the bio-pharmaceutical industry. Through the linkage between government guidance and private investment, the bio-pharmaceutical industry has shown a trend of agglomeration and development. Especially in the field of gene sequencing in China, the development of gene products companies represented by Huada Gene is rapid.
Market size analysis
In 2011-2013, the market scale of China's bio-pharmaceutical industry maintained a relatively fast growth rate. After 2013, the growth rate of the bio-pharmaceutical market slowed down. Among them, the sales revenue of the bio-pharmaceutical industry in 2013 was 238.136 billion yuan, a year-on-year increase of 34.13%, the largest increase in recent years. In 2016, the industry's sales revenue was 329.928 billion yuan, a year-on-year increase of 10.76%, and the growth rate was restored compared with 2015.
Chart 3: 2011-2016 China Bio-pharmaceutical Industry Market Scale Chart (Unit: 100 million yuan, % )
Source: Prospective Industry Research Institute
Market policy analysis
The bio-industry is the most active and far-reaching emerging industry in the 21st century. It is the main direction of China's strategic emerging industries, and it is crucial for China to seize the new round of scientific and technological revolution and the industrial revolution. In recent years, the country has issued a number of important plans and policies to help the development of the bio-industry, and the bio-pharmaceutical industry as one of the important branches of the bio-industry, its significance is self-evident.
Chart 4: List of important biomedical policies in China
Source: Prospective Industry Research Institute
China's biomedical market has great potential in the future
According to a report released by EvaluatePharma, the global biopharmaceutical penetration rate reached 25% in 2016, and the market penetration rate is expected to increase further to 30% in 2022.
In 2016, the scale of China's pharmaceutical market was 2,806.29 billion yuan, and the scale of biopharmaceuticals was 329.928 billion yuan. The market penetration rate was only 11.76%. As China's development of the biomedical industry is mentioned at the height of the national strategy, the research and development of biomedicine in China will further increase in the future, and the scale of the biomedical market will develop rapidly.
Organic hemp seed protein is a high-quality vegan protein. It is made from hulled hemp seeds by high concentration (cold-pressed). We choose the best quality hemp seeds as raw material, then we get the best hemp protein with fewer impurities and a high content of protein.
Organic hemp protein powder is a natural Plant Protein containing all 20 amino acids, including 9 essential amino acids and 2 semi-essential amino acids in the human body. Hemp protein also contains more than 20 minerals and trace elements.
Hemp protein has become one of the most popular natural protein powders. Organic hemp protein powder can be added to power drinks, smoothies or yogurt, sprinkled on various foods, fruits, or vegetables, used as a baking ingredient, or added to nutrition bars to promote the healthy growth of protein. Both hemp protein and hemp protein are ideal for baked goods and are very delicious after baking.
We can provide hemp protein with a protein content of 50%, 60%, and 70% respectively. Our organic hemp protein powder is specially treated with the fewest green husks, so it looks whiter than others.
Hemp Protein,Organic Hemp Protein Powder,Organic Hemp Protein,Hemp Seed Protein
Organicway (xi'an) Food Ingredients Inc. , https://www.organicwayince.com